247 related articles for article (PubMed ID: 24909172)
1. Mammary glands exhibit molecular laterality and undergo left-right asymmetric ductal epithelial growth in MMTV-cNeu mice.
Robichaux JP; Hallett RM; Fuseler JW; Hassell JA; Ramsdell AF
Oncogene; 2015 Apr; 34(15):2003-10. PubMed ID: 24909172
[TBL] [Abstract][Full Text] [Related]
2. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
Zinser GM; Welsh J
Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467
[TBL] [Abstract][Full Text] [Related]
4. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
Brantley-Sieders DM; Zhuang G; Hicks D; Fang WB; Hwang Y; Cates JM; Coffman K; Jackson D; Bruckheimer E; Muraoka-Cook RS; Chen J
J Clin Invest; 2008 Jan; 118(1):64-78. PubMed ID: 18079969
[TBL] [Abstract][Full Text] [Related]
5. Morphometric and fractal dimension analysis identifies early neoplastic changes in mammary epithelium of MMTV-cNeu mice.
Fuseler JW; Robichaux JP; Atiyah HI; Ramsdell AF
Anticancer Res; 2014 Mar; 34(3):1171-7. PubMed ID: 24596356
[TBL] [Abstract][Full Text] [Related]
6. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA
Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967
[TBL] [Abstract][Full Text] [Related]
7. Noncanonical TGF-β signaling during mammary tumorigenesis.
Parvani JG; Taylor MA; Schiemann WP
J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):127-46. PubMed ID: 21448580
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR-489 derails mammary hierarchy structure and inhibits HER2/neu-induced tumorigenesis.
Patel Y; Soni M; Awgulewitsch A; Kern MJ; Liu S; Shah N; Singh UP; Chen H
Oncogene; 2019 Jan; 38(3):445-453. PubMed ID: 30104710
[TBL] [Abstract][Full Text] [Related]
9. Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression.
Chen F; Li A; Gao S; Hollern D; Williams M; Liu F; VanSickle EA; Andrechek E; Zhang C; Yang C; Luo R; Xiao H
Cell Death Dis; 2014 May; 5(5):e1242. PubMed ID: 24853420
[TBL] [Abstract][Full Text] [Related]
10. Left-right analysis of mammary gland development in retinoid X receptor-α+/- mice.
Robichaux JP; Fuseler JW; Patel SS; Kubalak SW; Hartstone-Rose A; Ramsdell AF
Philos Trans R Soc Lond B Biol Sci; 2016 Dec; 371(1710):. PubMed ID: 27821527
[TBL] [Abstract][Full Text] [Related]
11. Attenuated TGFB signalling in macrophages decreases susceptibility to DMBA-induced mammary cancer in mice.
Sun X; Bernhardt SM; Glynn DJ; Hodson LJ; Woolford L; Evdokiou A; Yan C; Du H; Robertson SA; Ingman WV
Breast Cancer Res; 2021 Mar; 23(1):39. PubMed ID: 33761981
[TBL] [Abstract][Full Text] [Related]
12. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.
Asselin-Labat ML; Sutherland KD; Vaillant F; Gyorki DE; Wu D; Holroyd S; Breslin K; Ward T; Shi W; Bath ML; Deb S; Fox SB; Smyth GK; Lindeman GJ; Visvader JE
Mol Cell Biol; 2011 Nov; 31(22):4609-22. PubMed ID: 21930782
[TBL] [Abstract][Full Text] [Related]
13. RARα1 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis.
Cohn E; Ossowski L; Bertran S; Marzan C; Farias EF
Breast Cancer Res; 2010; 12(5):R79. PubMed ID: 20923554
[TBL] [Abstract][Full Text] [Related]
14. Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice.
Hodgson MC; Vanostran G; Alghamdi S; Poppiti RJ; Agoulnik AI; Agoulnik IU
PLoS One; 2013; 8(4):e60455. PubMed ID: 23593223
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways.
Lim E; Wu D; Pal B; Bouras T; Asselin-Labat ML; Vaillant F; Yagita H; Lindeman GJ; Smyth GK; Visvader JE
Breast Cancer Res; 2010; 12(2):R21. PubMed ID: 20346151
[TBL] [Abstract][Full Text] [Related]
16. A requirement for Nedd9 in luminal progenitor cells prior to mammary tumorigenesis in MMTV-HER2/ErbB2 mice.
Little JL; Serzhanova V; Izumchenko E; Egleston BL; Parise E; Klein-Szanto AJ; Loudon G; Shubina M; Seo S; Kurokawa M; Ochs MF; Golemis EA
Oncogene; 2014 Jan; 33(4):411-20. PubMed ID: 23318423
[TBL] [Abstract][Full Text] [Related]
17. Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium.
Tarulli GA; De Silva D; Ho V; Kunasegaran K; Ghosh K; Tan BC; Bulavin DV; Pietersen AM
Breast Cancer Res; 2013 Jan; 15(1):R10. PubMed ID: 23369183
[TBL] [Abstract][Full Text] [Related]
18. ErbB2/Neu-induced, cyclin D1-dependent transformation is accelerated in p27-haploinsufficient mammary epithelial cells but impaired in p27-null cells.
Muraoka RS; Lenferink AE; Law B; Hamilton E; Brantley DM; Roebuck LR; Arteaga CL
Mol Cell Biol; 2002 Apr; 22(7):2204-19. PubMed ID: 11884607
[TBL] [Abstract][Full Text] [Related]
19. The role of activin in mammary gland development and oncogenesis.
Dunphy KA; Schneyer AL; Hagen MJ; Jerry DJ
J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):117-26. PubMed ID: 21475961
[TBL] [Abstract][Full Text] [Related]
20. Positional variations in mammary gland development and cancer.
Veltmaat JM; Ramsdell AF; Sterneck E
J Mammary Gland Biol Neoplasia; 2013 Jun; 18(2):179-88. PubMed ID: 23666389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
